151 results on '"Martínez-Cuadrón D"'
Search Results
2. Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy
3. A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia
4. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis
5. P545: CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND TRISOMY 19
6. P511: RISK FACTORS AND INCIDENCE OF CARDIAC EVENTS IN A LARGE COHORT OF 525 ADULT PATIENTS WITH NEWLY DIAGNOSED NON-M3 ACUTE MYELOID LEUKEMIA
7. PB1845: ACUTE MYELOID LEUKEMIA IN THE ELDERLY: A MULTICENTER EXPERIENCE IN COLOMBIA, ON BEHALF OF ACHO’S RENEHOC INVESTIGATORS
8. P569: GILTERITINIB AND QUIZARTINIB IN RELAPSED/REFRACTORY (R/R) ACUTE MYELOBLASTIC LEUKEMIA (AML) WITH FLT3 MUTATIONS: A REAL-LIFE EFFECTIVENESS AND SAFETY STUDY
9. P512: PRELIMINARY RESULTS OF VEN-A-QUI STUDY: A PHASE 1-2 TRIAL TO ASSESS THE SAFETY AND EFFICACY OF THE COMBINATION OF AZACITIDINE OR LOW-DOSE CYTARABINE WITH VENETOCLAX AND QUIZARTINIB IN NEWLY DIAGNOSED
10. Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain
11. Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia
12. EFFECT OF CD8+ CELL CONTENT ON UMBILICAL CORD BLOOD TRANSPLANTATION IN ADULTS WITH HEMATOLOGICAL MALIGNANCIES: PH-O104
13. Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?
14. Tyrosine kinase inhibitors for acute myeloid leukemia: A step toward disease control?
15. Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study (vol 92, 106352, 2020)
16. Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation
17. Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
18. Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia
19. Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity
20. Real life outcomes of patients aged =75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry
21. A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients
22. A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia
23. S1614 CHROMOSOMAL ABNORMALITIES DETERMINE OUTCOME IN NPM1MUT/FLT3-ITDNEG/LOW ACUTE MYELOID LEUKEMIA
24. PF221 MUTATIONAL PROFILE BY NGS COMBINED WITH EX VIVO DRUG SENSITIVITY PROFILE IMPROVE PREDICTION OF AML PATIENT OUTCOME
25. PF216 ROLE OF MEASURABLE RESIDUAL DISEASE (MRD) IN REDEFINING COMPLETE RESPONSE (CR) IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM THE PETHEMA-FLUGAZA PHASE III CLINICAL TRIAL
26. Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin
27. Pharmacogenomics and the treatment of acute myeloid leukemia
28. Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy
29. PKP-003 Influence of cytarabine metabolic pathway polymorphisms in effectiveness of acute myeloid leukaemia induction treatment
30. Time and Cost of Hospitalization for Salvage Therapy Among Adults with Philadelhphia (PH)-Negative B-Cell Relapsed/Refractory (R/R) Acute Lymphoblastic Leukaemia (ALL) In Spain
31. Treatment of invasive fungal disease using anidulafungin alone or in combination for hematologic patients with concomitant hepatic or renal impairment
32. Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia
33. PKP-020 Impact of nadph oxidase functional polymorphisms in acute myeloid leukaemia induction chemotherapy
34. A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia
35. BRAF V600E mutation in adult acute lymphoblastic leukemia
36. WT1 isoform expression pattern in acute myeloid leukemia
37. Significance of Increased Blastic-Appearing Cells in Bone Marrow Following Myeloablative Unrelated Cord Blood Transplantation in Adult Patients
38. Analysis of SNP rs16754 of WT1 gene in a series of de novo acute myeloid leukemia patients
39. Rapid screening of ASXL1, IDH1, IDH2, and c-CBL mutations in de novo acute myeloid leukemia by high-resolution melting
40. A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia
41. Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia
42. Central nervous system involvement at first relapse in patients with acute myeloid leukemia
43. PKP-005 Prognostic impact of novel gene polymorphisms in newly diagnosed acute myeloid leukaemia adults undergoing induction chemotherapy: Abstract PKP-005 Table 1
44. PCN98 - Time and Cost of Hospitalization for Salvage Therapy Among Adults with Philadelhphia (PH)-Negative B-Cell Relapsed/Refractory (R/R) Acute Lymphoblastic Leukaemia (ALL) In Spain
45. Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy
46. A systematic review and meta-analysis of the impact of WT1polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia
47. Epstein-Barr Virus-Related Complications (EBV-RC) After Umbilical Cord Blood Transplantation (UCBT) for Adult Patients with High-Risk Hematologic Malignancies
48. Cord Blood Transplantation from Unrelated Donors Versus Stem Cell Transplantation from HLA-Identical Sibling in Adults with Philadelphia-Positive Acute Lymphoblastic Leukemia
49. Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
50. The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.